Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: a single centre study of 212 anti-Ro52 positive pregnancies

What is it about?

Assuming that autoimmune congenital heart block (CHB) is a progressive disease amenable to therapeutic modulation, we introduced a fetal surveillance program of autoantibody-positive pregnant women at risk. We experienced that CHB developed within days and was not possible to predict, but that a prompt diagnosis and treatment seemed to have a positive effect on outcome.

Featured Image